| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Prospective Study |
| Article Title |
Feasibility and efficacy of delayed pharmacoinvasive therapy for ST-elevation myocardial infarction
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rishi Sethi, Lalit Mohan, Pravesh Vishwakarma, Abhishek Singh, Swati Sharma, Monika Bhandari, Ayush Shukla, Akhil Sharma, Gaurav Chaudhary, Akshyaya Pradhan, Sharad Chandra, Varun Shankar Narain and Sudhanshu Kumar Dwivedi |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Akshyaya Pradhan, MD, Professor, Department of Cardiology, King George's Medical University, Shah Mina Road, Chowk, Lucknow, Uttar pardesh 226003, Lucknow 226003, Uttar Pradesh, India. akshyaya33@gmail.com |
| Key Words |
Coronary artery disease; ST-elevation myocardial infarction; Primary percutaneous coronary intervention; Pharmacoinvasive strategy; Thrombolysis; Atherosclerosis |
| Core Tip |
Pharmacoinvasive strategy with percutaneous coronary intervention (PCI) within 3 to 24 h after successful thrombolysis has been proven to be a viable alternative to primary PCI. In resource poor countries, patients often present to interventionist beyond 24 h of thrombolysis. The results of this study demonstrate that the clinical outcomes of delayed pharmacoinvasive therapy (24-72 h of initiation of thrombolysis) are comparable to routine pharmacoinvasive (3-24 h of initiation of thrombolysis) in patients with acute STEMI. Hence, in critically diseased acute STEMI patients who have been timey thrombolysed, delayed PCI (24-72 h following thrombolysis) appears a reasonable strategy. |
| Publish Date |
2023-01-12 04:00 |
| Citation |
Sethi R, Mohan L, Vishwakarma P, Singh A, Sharma S, Bhandari M, Shukla A, Sharma A, Chaudhary G, Pradhan A, Chandra S, Narain VS, Dwivedi SK. Feasibility and efficacy of delayed pharmacoinvasive therapy for ST-elevation myocardial infarction. World J Cardiol 2023; 15(1): 23-32 |
| URL |
https://www.wjgnet.com/1949-8462/full/v15/i1/23.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v15.i1.23 |
